Newsletter March 2022 No.208
Top News
On January 20, 2022, the "Pharmaceutical Manufacturers Association of Japan Press Conference" was held at Nomura Conference Plaza Nihonbashi (Chuo-ku, Tokyo). Yasushi Okada, Chairman of the Pharmaceutical Manufacturers Association of Japan (PMAJ), gave a 25-minute presentation focusing on "At the Start of Discussion on Pharmaceutical Industry Policy: Current Status and Recognition of Issues". Although the event was webcast from the viewpoint of preventing the spread of infectious diseases, 40 people from 21 media companies attended the event and engaged in a lively Q&A session. The following is a summary of Chairman Okada's presentation and the Q&A session.
Topics
- Special Program at the 8th Nikkei-FT Conference on Infectious Diseases Preparedness for Emerging and Re-emerging Infectious Diseases including Drug Resistant Bacteria - Unknown Threats, Unified National Response
- The 5th Japan-India Symposium on Regulation of Medical Products in Japan Proactive Communication for Development of Japan-India Cooperation Scheme in the Field of Pharmaceuticals
- Held "Regular Meeting with the Association of the British Pharmaceutical Industry (ABPI)
- Held regular meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
- CMC Strategy Forum Japan 2021" held
- Holding of the "Pharmaceutical Cooperative Media Forum" Vaccination in the Era of With-Corona: Learning from Pandemics
Policy Research Institute page
From JPMA
On the Start of Discussions on Pharmaceutical Industry Policies
Citizens, Patients and Musubu
Information
- Major Activity Reports and Planned Activities
- The FY2021 Pharmaceutical Association of Japan (PAK) Communication Plan is being developed
- Establishment of the official Twitter account of the Pharmaceutical Manufacturers Association of Japan (PAK) - A place for a wide range of people to express their interest in the pharmaceutical industry